Log in to save to my catalogue

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank...

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b44106170c24e29b9e24c494b97cbfb

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population

About this item

Full title

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population

Publisher

England: BioMed Central

Journal title

Journal of translational medicine, 2022-11, Vol.20 (1), p.550-550, Article 550

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

Pharmacogenomics (PGx) aims to utilize a patient's genetic data to enable safer and more effective prescribing of medications. The Clinical Pharmacogenetics Implementation Consortium (CPIC) provides guidelines with strong evidence for 24 genes that affect 72 medications. Despite strong evidence linking PGx alleles to drug response, there is a large...

Alternative Titles

Full title

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7b44106170c24e29b9e24c494b97cbfb

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7b44106170c24e29b9e24c494b97cbfb

Other Identifiers

ISSN

1479-5876

E-ISSN

1479-5876

DOI

10.1186/s12967-022-03745-5

How to access this item